Deep sequencing identifies IDH1 R132S mutation in adult medulloblastoma

Journal of Clinical Oncology

Volumn 33, Issue 6, 2015, Pages e27-e31

  Snuderl, Matija ^a   Triscott, Joanna ^b   Northcott, Paul A ^c   Shih, Helen A ^d   Kong, Esther ^b   Robinson, Hayley ^d   Dunn, Sandra E ^b   Iafrate, A John ^d   Yip, Stephen ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; DICKKOPF 1 PROTEIN; GADOLINIUM; ISOCITRATE DEHYDROGENASE 1; MYC PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; POTASSIUM CHANNEL KV1.1; PROTEIN P53; PROTEIN PATCHED 1; SECRETED FRIZZLED RELATED PROTEIN 1; SONIC HEDGEHOG PROTEIN; SYNAPTOPHYSIN; TRANSCRIPTION FACTOR GLI2; WNT4 PROTEIN; IDH1 PROTEIN, HUMAN; ISOCITRATE DEHYDROGENASE;

ADULT; ANOREXIA; ARTICLE; BRAIN BIOPSY; BRAIN EDEMA; BRAIN LYMPHOMA; CANCER ADJUVANT THERAPY; CANCER STAGING; CASE REPORT; CEREBELLUM CORTEX; CEREBELLUM DISEASE; CHROMOSOME 16; CHROMOSOME DELETION; CHROMOSOME LOSS; COMPARATIVE GENOMIC HYBRIDIZATION; CONTRAST ENHANCEMENT; CRANIOSPINAL IRRADIATION; DIZZINESS; FATIGUE; FEMALE; GENE EXPRESSION PROFILING; GENE LOCUS; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; HEADACHE; HOMOZYGOSITY; HUMAN; IMMUNOHISTOCHEMISTRY; MEDULLOBLASTOMA; MIDDLE AGED; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEOTIDE SEQUENCE; POSTERIOR CRANIAL FOSSA TUMOR; PRIORITY JOURNAL; PROTON THERAPY; REPEAT PROCEDURE; RNA EXTRACTION; SMALL CELL LUNG CANCER; SOMNOLENCE; SUBARACHNOID SPACE; TUMOR VOLUME; UPREGULATION; CEREBELLUM TUMOR; GENETICS; MUTATION;

CEREBELLAR NEOPLASMS; FEMALE; HUMANS; ISOCITRATE DEHYDROGENASE; MEDULLOBLASTOMA; MIDDLE AGED; MUTATION;

EID: 84923165577     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.49.4864     Document Type: Article

References (24)

1. Taylor MD, Northcott PA, Korshunov A, et al: Molecular subgroups of medulloblastoma: The current consensus. Acta Neuropathol 123:465-472, 2012
2. Northcott PA, Shih DJ, Remke M, et al: Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples. Acta Neuropathol 123:615-626, 2012
3. Pugh TJ, Weeraratne SD, Archer TC, et al: Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 488:106-110, 2012
4. Northcott PA, Shih DJ, Peacock J, et al: Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature 488:49-56, 2012
5. Snuderl M, Fazlollahi L, Le LP, et al: Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. Cancer Cell 20:810-817, 2011
6. Yang MM, Singhal A, Rassekh SR, et al: Possible differentiation of cerebral glioblastoma into pleomorphic xanthoastrocytoma: An unusual case in an infant. J Neurosurg Pediatr 9:517-523, 2012
7. Horbinski C, Kofler J, Kelly LM, et al: Diagnostic use of IDH1/2 mutation analysis in routine clinical testing of formalin-fixed, paraffin-embedded glioma tissues. J Neuropathol Exp Neurol 68:1319-1325, 2009
8. Packer RJ, Boyett JM, Janss AJ, et al: Growth hormone replacement therapy in children with medulloblastoma: Use and effect on tumor control. J Clin Oncol 19:480-487, 2001
9. Laughton SJ, Merchant TE, Sklar CA, et al: Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial. J Clin Oncol 26:1112-1118, 2008
10. Fouladi M, Gilger E, Kocak M, et al: Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies. J Clin Oncol 23:7152-7160, 2005
11. Walter AW, Mulhern RK, Gajjar A, et al: Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital. J Clin Oncol 17:3720-3728, 1999
12. Mulhern RK, Palmer SL, Merchant TE, et al: Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. J Clin Oncol 23:5511-5519, 2005
13. Goldstein AM, Yuen J, Tucker MA: Second cancers after medulloblastoma: Population-based results from the United States and Sweden. Cancer Causes Control 8:865-871, 1997
14. Oyharcabal-Bourden V, Kalifa C, Gentet JC, et al: Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: A French Society of Pediatric Oncology Study. J Clin Oncol 23:4726-4734, 2005
15. Packer RJ, Goldwein J, Nicholson HS, et al: Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. J Clin Oncol 17:2127-2136, 1999
16. Grill J, Lellouch-Tubiana A, Elouahdani S, et al: Preoperative chemotherapy in children with high-risk medulloblastomas: A feasibility study. J Neurosurg 103:312-318, 2005
17. Rudin CM, Hann CL, Laterra J, et al: Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N Engl J Med 361:1173-1178, 2009
18. Yan H, Parsons DW, Jin G, et al: IDH1 and IDH2 mutations in gliomas. N Engl J Med 360:765-773, 2009
19. Parsons DW, Li M, Zhang X, et al: The genetic landscape of the childhood cancer medulloblastoma. Science 331:435-439, 2010
20. Jones DT, Jäger N, Kool M, et al: Dissecting the genomic complexity underlying medulloblastoma. Nature 488:100-105, 2012
21. Fellay CN, Frappaz D, Sunyach MP, et al: Medulloblastomas in adults: Prognostic factors and lessons from paediatrics. Curr Opin Neurol 24:626-632, 2011
22. Remke M, Hielscher T, Northcott PA, et al: Adult medulloblastoma comprises three major molecular variants. J Clin Oncol 29:2717-2723, 2011
23. Northcott PA, Hielscher T, Dubuc A, et al: Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct. Acta Neuropathol 122:231-240, 2011
24. Korshunov A, Remke M, Werft W, et al: Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification. J Clin Oncol 28:3054-3060, 2010